Balloon Sinuplasty: Indications, Procedure, and Postoperative Management
When Balloon Sinuplasty is Indicated
Balloon sinuplasty is indicated for adults with chronic rhinosinusitis without nasal polyps (CRSsNP) or recurrent acute rhinosinusitis (RARS) affecting the frontal, maxillary, or sphenoid sinuses who have failed appropriate medical therapy, but it should NOT be used when polyps, osteitis, bony erosion, or fungal disease are present 1, 2.
Specific Patient Selection Criteria:
Appropriate candidates:
- CRSsNP with limited disease burden confined to frontal, maxillary, or sphenoid sinuses
- RARS refractory to prolonged antibiotics, corticosteroids, and adjuvant therapies
- CT scan demonstrating sinus disease with corresponding sinonasal symptoms
- Patients who cannot tolerate general anesthesia (can be performed in-office) 2, 3
Contraindications (must use full endoscopic sinus surgery instead):
- Nasal polyposis (pansinus or localized)
- Osteitis or bony erosion on CT
- Fungal sinusitis (allergic fungal or fungal balls)
- Significant ethmoid disease requiring tissue removal
- Suspected malignancy
- Advanced connective tissue disorders
- Headache without meeting diagnostic criteria for CRS/RARS 1, 2
Critical Pitfall:
The 2025 AAO-HNS guideline explicitly states that balloon or manual ostial dilation alone is insufficient when polyps, osteitis, bony erosion, or fungal disease are present—these require full exposure of the sinus cavity with diseased tissue removal 1. Using balloon sinuplasty in these scenarios leads to treatment failure and unnecessary revision surgery.
Preoperative Requirements
Before proceeding with balloon sinuplasty:
Verify CRS diagnosis using established diagnostic criteria (symptoms plus objective findings) 1
Obtain fine-cut CT scan for surgical planning if not already available 1
Counsel patients on realistic expectations including:
- Potential for disease chronicity or relapse
- Likelihood of long-term medical management postoperatively
- That surgery augments but does not replace medical therapy 1
Educate about postoperative care specifically addressing pain control, debridement needs, medical management continuation, activity restrictions, return to work timing, follow-up frequency (3-12 months), and revision surgery potential 1
How the Procedure is Performed
Balloon sinuplasty can be performed in-office under local anesthesia or in the operating room:
Technical approach:
- Endoscopic visualization with telescope and video system
- Guide catheter inserted into target sinus ostium
- Balloon catheter advanced through guide wire
- Balloon inflated to 8-12 atmospheres, creating microfractures in surrounding bone
- Ostium dilated to restore patency without tissue removal
- Balloon deflated and removed
- Natural anatomy and mucosa preserved 2, 4, 5
Technical success rates:
- 89-94% success rate for frontal sinus dilation 3, 6
- Can be combined with traditional FESS (hybrid approach) when ethmoid disease coexists 6
In-office feasibility:
- 93% of patients report procedure as tolerable or highly tolerable
- 66% experience no pain or low-intensity pain
- 33% report higher pain during balloon inflation
- Local anesthesia with topical and injectable agents sufficient 3
Postoperative Care and Follow-Up
Immediate Postoperative Management:
Pain control:
- Acetaminophen as first-line (median 3 combination tablets needed)
- NSAIDs do not increase bleeding risk and decrease opioid requirements
- Reserve opioids for patients with history of antidepressant use or inadequate response to non-narcotics
- Pain peaks in first 3 days 1
Medical management:
- Resume or initiate nasal saline irrigation (improves mucociliary clearance and crusting resolution)
- Continue or start intranasal corticosteroids (associated with higher patient satisfaction) 6
- Clarify timing for resuming any perioperatively held medications 1
Activity restrictions:
- Provide specific guidance on physical activity limitations
- Define return to work timeline 1
Long-Term Follow-Up Protocol:
The surgeon must routinely follow up between 3-12 months postoperatively to assess and document outcomes through:
History assessment:
Nasal endoscopy:
Revision Surgery Considerations:
- Overall revision rate: 15.7% 6
- Previous sinonasal surgery predicts 3-fold higher revision rate (OR 3.03) 6
- Hybrid approach (balloon + traditional FESS) results in fewer reoperations than balloon-only (OR 0.33) 6
- Balloon sinuplasty appears insufficient for revision cases—consider full FESS instead 6
- 88.5% of patients report long-term benefit, with 95% stating they would undergo procedure again 3, 6
Key Success Factor:
Continued use of nasal corticosteroids postoperatively significantly increases patient satisfaction (OR 8.26) 6.